[Federal Register Volume 72, Number 45 (Thursday, March 8, 2007)]
[Notices]
[Pages 10563-10564]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: E7-4099]


=======================================================================
-----------------------------------------------------------------------

NATIONAL AERONAUTICS AND SPACE ADMINISTRATION

[Notice 07-022]


Notice of Intent To Grant Partially Exclusive License

AGENCY: National Aeronautics and Space Administration.

ACTION: Notice of intent to grant exclusive license

-----------------------------------------------------------------------

SUMMARY: This notice is issued in accordance with 35 U.S.C. 209(c)(1) 
and 37 CFR 404.7(a)(1)(i). NASA hereby gives notice of its intent to 
grant a partially exclusive license worldwide to practice the 
inventions described and claimed in U.S. Patent Nos. 5,155,035, 
entitled `` Method for Culturing Mammalian Cells in a Perfused 
Bioreactor''; 5,153,133, entitled ``Method for Culturing Mammalian 
Cells in a Horizontally Rotated Bioreactor''; 5,155,034, entitled 
``Three Dimensional Cell to Tissue Assembly Process''; 5,153,132, 
entitled ``Three-Dimensional Co-culture Process''; 5,308,764, entitled 
``Multi-Cellular Three-Dimensional Living Mammalian Tissue''; 
5,627,021, entitled ``Three-Dimensional Co-Culture Process''; 
5,153,131, entitled ``High Aspect Reactor Vessel and Method of Use''; 
5,496,722, entitled ``Method for Producing Non-neoplastic, Three-
dimensional, Mammalian Tissue and Cell Aggregates under Microgravity 
Culture Conditions and the Products Produced Therefrom''; 5,846,807, 
entitled ``Media Compositions for Three-dimensional Mammalian Tissue 
Grown under Microgravity Culture Conditions''; 5,858,783, entitled 
``Production of Normal Mammalian Organ Culture Using a Medium 
Containing MEM-alpha, Leibovitz L-15, Glucose Galactose Fructose''; 
5,962,324, entitled ``Three Dimensional Optic Tissue Culture and 
Process''; 6,485,963, entitled ``Growth Stimulation of Biological Cells 
and Tissue by Electromagnetic Fields and Uses Thereof'', 6,673,597, 
entitled ``Growth Stimulation of Biological Cells and Tissue by 
Electromagnetic Fields and Uses Thereof''; 6,730,498, entitled 
``Production of Functional Proteins: Balance of Shear Stress and 
Gravity''; 6,946,246, entitled ``Production of Functional Proteins: 
Balance of Shear Stress and Gravity'', U.S. Patent Application Serial 
Number 10/734,759, entitled ``Production of Functional Proteins: 
Balance of Shear Stress and Gravity'', U.S. Patent Application Serial 
Number 10/947,786, entitled ``Production of Functional Proteins: 
Balance of Shear Stress and Gravity'', Foreign Patent No. 0423277 
``Bio-Reactor Cell Culture Process'', Foreign Patent No. 1987294, 
``Bio-Reactor Cell Culture Process'', International Application No. 
PCT/US98/06826, European Application No. 98915320.0 entitled 
``Production of Functional Proteins: Balance of Shear Stress and 
Gravity'', International Application No. PCT/US98/06826, Japanese 
Application No. 10-540983 entitled ``Production of Functional Proteins: 
Balance of Shear Stress and Gravity'', International Application No. 
PCT/US98/06826, Canadian Application No. 2286349 entitled ``Production 
of Functional Proteins: Balance of Shear Stress and Gravity'', 
International Application No. PCT/US98/06826, Israeli Application No. 
132264 entitled ``Production of Functional Proteins: Balance of Shear 
Stress and Gravity'', International Application No. PCT/US98/06826, 
Mexican Application No. 999265 entitled ``Production of Functional 
Proteins: Balance of Shear Stress and Gravity'', and International 
Application No. PCT/US98/06826, Brazilian Application No. 98915320.0 
entitled ``Production of Functional Proteins: Balance of Shear Stress 
and Gravity'', to Aedifico Biosciences, Inc., having its principal 
place of business in Beverly Hills, California. The fields of use may 
be limited to cosmetics and personal care products. The patent rights 
in these inventions have been assigned to the United States of America 
as represented by the Administrator of the National Aeronautics and 
Space Administration. The prospective partially exclusive license will 
comply with the terms and conditions of 35 U.S.C. 209 and 37 CFR 404.7.

DATES: The prospective partially exclusive license may be granted 
unless, within fifteen (15) days from the date of this published 
notice, NASA receives written objections including evidence and 
argument that establish that the grant of the license would not be 
consistent with the requirements of 35 U.S.C. 209 and 37 CFR 404.7. 
Competing applications completed and received by NASA within fifteen 
(15) days of the date of this published notice will also be treated as 
objections to the grant of the contemplated partially exclusive 
license. Objections submitted in response to this notice will not be 
made available to the public for inspection and, to the extent 
permitted by law, will not be released under the Freedom of Information 
Act, 5 U.S.C. 552.

ADDRESSES: Objections relating to the prospective license may be 
submitted to Patent Counsel, Office of Chief Counsel, Mail Code AL, 
2101 NASA Parkway, Houston, TX 77058, (281) 483-4871; (281) 483-6936 
[Facsimile].

FOR FURTHER INFORMATION CONTACT: Kurt G. Hammerle, Patent Attorney, 
Office of Chief Counsel, Johnson Space Center, Mail Code AL, 2101 NASA 
Parkway, Houston, TX 77058, (281)483-1001; (281)483-6936 [Facsimile]. 
Information about other NASA inventions available for licensing can be 
found online at http://technology.nasa.gov/.


[[Page 10564]]


    Dated: March 1, 2007.
Keith T. Sefton,
Deputy General Counsel, Administration & Management.
 [FR Doc. E7-4099 Filed 3-7-07; 8:45 am]
BILLING CODE 7510-13-P